Outlook Therapeutics Files Prospectus For Offering 17.258M Common Shares On Behalf Of Selling Stockholders

Benzinga Newsdesk www.benzinga.com Neutral 92.8%

Neg 0% Neu 92.8% Pos 0%

https://www.sec.gov/Archives/edgar/data/1649989/000110465926084621/tm2619649d3_s3.htm

Comments

No comments yet. Be the first!